DEXILANT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexilant, and what generic alternatives are available?
Dexilant is a drug marketed by Takeda Pharms Usa and is included in two NDAs. There are twelve patents protecting this drug and one Paragraph IV challenge.
This drug has one hundred and twenty patent family members in thirty-one countries.
The generic ingredient in DEXILANT is dexlansoprazole. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dexlansoprazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexilant
A generic version of DEXILANT was approved as dexlansoprazole by PAR PHARM INC on April 19th, 2017.
Summary for DEXILANT
International Patents: | 120 |
US Patents: | 10 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Clinical Trials: | 31 |
Patent Applications: | 599 |
Drug Prices: | Drug price information for DEXILANT |
Drug Sales Revenues: | Drug sales revenues for DEXILANT |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DEXILANT |
What excipients (inactive ingredients) are in DEXILANT? | DEXILANT excipients list |
DailyMed Link: | DEXILANT at DailyMed |
Recent Clinical Trials for DEXILANT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
SAMI Pharmaceutical, Karachi Pakistan | Phase 1 |
University of Karachi | Phase 1 |
Taipei Veterans General Hospital, Taiwan | N/A |
Pharmacology for DEXILANT
Drug Class | Proton Pump Inhibitor |
Mechanism of Action | Proton Pump Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for DEXILANT
Paragraph IV (Patent) Challenges for DEXILANT
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
DEXILANT | Delayed-release Capsules | dexlansoprazole | 30 mg | 022287 | 1 | 2010-11-30 |
US Patents and Regulatory Information for DEXILANT
DEXILANT is protected by seven US patents.
Patents protecting DEXILANT
Multiple PPI dosage form
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Controlled release preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Controlled release preparation
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Method for producing granules
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Method for producing granules
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: USE OF DEXLANSOPRAZOLE IN PATIENTS TAKING CLOPIDOGREL WITHOUT MEANINGFUL CYP2C19 INTERACTIONS
Multiple PPI dosage form
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Takeda Pharms Usa | DEXILANT SOLUTAB | dexlansoprazole | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL | 208056-001 | Jan 26, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEXILANT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-002 | Jan 30, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Takeda Pharms Usa | DEXILANT | dexlansoprazole | CAPSULE, DELAYED RELEASE;ORAL | 022287-001 | Jan 30, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEXILANT
See the table below for patents covering DEXILANT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1338377 | COMPOSITION PHARMACEUTIQUE STABILISEE ET SA PREPARATION (STABILIZED PHARMACEUTICAL COMPOSITION AND ITS PRODUCTION) | ⤷ Try a Trial |
Japan | 2014012692 | METHODS OF TREATING GASTROINTESTINAL DISORDERS INDEPENDENT OF INTAKE OF FOOD | ⤷ Try a Trial |
Germany | 3750431 | ⤷ Try a Trial | |
Slovenia | 1129088 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DEXILANT
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1129088 | 2014/008 | Ireland | ⤷ Try a Trial | PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919 |
1129088 | 1490004-7 | Sweden | ⤷ Try a Trial | PRODUCT NAME: DEXLANSOPRAZOL; REG. NO/DATE: 47912, 47913, 47914 20130919 |
1129088 | PA2014014,C1129088 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: DEXLANSOPRAZOLUM; REGISTRATION NO/DATE: LT/1/13/3415/001 - LT/1/13/3415/004, 2013 10 31 LT/1/13/3416/001 - LT/1/13/3416/004 20131031 |
1129088 | C 2014 021 | Romania | ⤷ Try a Trial | PRODUCT NAME: DEXLANSOPRAZOL(R)-2-([3-METIL-4-(2,2,2-TRIFLUOROETOXI)PIRIDIN-2-IL]METILSULFINIL)-1H-BENZIMIDAZOL; NATIONAL AUTHORISATION NUMBER: RO6090/2014/01, RO6090/2014/02; DATE OF NATIONAL AUTHORISATION: 20140120; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SE 47911; DATE OF FIRST AUTHORISATION IN EEA: 20130919 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |